Serum lipoproteins improve after successful pharmacologic antidepressant treatment: A randomized open-label prospective trial

Journal of Clinical Psychiatry

Volumn 72, Issue 7, 2011, Pages 885-891

  Hummel, Jana ^a   Westphal, Sabine ^b   Weber Hamann, Bettina ^a   Gilles, Maria ^a   Lederbogen, Florian ^a   Angermeier, Tobias ^a   Luley, Claus ^b   Deuschle, Michael ^a   Kopf, Daniel ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIRTAZAPINE; TRIACYLGLYCEROL; VENLAFAXINE;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HOSPITAL; OPEN STUDY; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 79960712810     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05853blu     Document Type: Article

References (36)

1. Partonen T, Haukka J, Virtamo J, et al. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999;175(3):259-262. doi:10.192/bjp.175.3.259 (Pubitemid 29406596)
2. Morgan RE, Palinkas LA, Barrett-Connor EL, et al. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993;341(8837):75-79. doi:10.1016/0140-6736(93)9256-9 (Pubitemid 23028114)
3. Glueck CJ, Tieger M, Kunkel R, et al. Hypocholesterolemia and affective disorders. Am J Med Sci. 1994;308(4):218-225. (Pubitemid 24355588)
4. Olusi SO, Fido AA. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry. 1996;40(11):1128-1131. doi:10.1016/S06-323(95)059-4 (Pubitemid 26400877)
5. Huang TL, Wu SC, Chiang YS, et al. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Res. 2003;118(2):147-153. doi:10.1016/S0165- 1781(03)071-4
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. doi:10.101/jama.285.19.2486
7. Ladwig KH, Kieser M, König J, et al. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J. 1991;12(9):959-964.
8. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 1993;4(4):285-294. doi:10.1097/01648-193070-03 (Pubitemid 23199705)
9. Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study: National Health and Nutrition Examination Survey. Arch Intern Med. 2000;160(9):1261-1268. doi:10.101/archinte.160.9.1261 (Pubitemid 30252771)
10. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58(3):221-227. doi:10.101/archpsyc.58.3.21 (Pubitemid 32209674)
11. Lespérance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-1053. doi:10.161/hc0902.104707 (Pubitemid 34212612)
12. Lederbogen F, Deuschle M, Heuser I. [Depression: a cardiovascular risk factor] [article in German]. Internist (Berl). 1999;40(10):1119-1121. doi:10.107/s010805045
13. Rabe-Jaboñska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit. 2000;6(3):539-547. (Pubitemid 30432141)
14. Gabriel A. Changes in plasma cholesterol in mood disorder patients: does treatment make a difference? J Affect Disord. 2007;99(1-3):273-278. doi:10.1016/j.jad.206.08.015
15. Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health. 2005;26(1):469-500. doi:10.146/anurev. publhealth.26.021304.14542 (Pubitemid 40547393)
16. Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298(7):776-785. doi:10.101/jama.298.7.76 (Pubitemid 47263160)
17. Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260(13):1917- 1921. doi:10.101/jama.260.13.1917
18. Weber B, Schweiger U, Deuschle M, et al. Major depression and impaired glucose tolerance. Exp Clin Endocrinol Diabetes. 2000;108(3):187-190. doi:10.105/s-20-742 (Pubitemid 30315896)
19. Ambrosch A, Mühlen I, Kopf D, et al. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care. 1998;21(12):2077-2084. doi:10.237/diacare.21.12.207 (Pubitemid 28549154)
20. Weber-Hamann B, Gilles M, Lederbogen F, et al. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. J Clin Psychiatry. 2006;67(12):1856-1861. doi:10.408/JCP.v67n1204 (Pubitemid 46048182)
21. Weber-Hamann B, Gilles M, Schilling C, et al. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. J Clin Psychopharmacol. 2008;28(5):581-584. doi:10.1097/JCP.0b013e31818582ef
22. Kraus T, Haack M, Schuld A, et al. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry. 2002;35(6):220-225. doi:10.105/s-202-36390 (Pubitemid 36061311)
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56
24. Aijänseppä S, Kivinen P, Helkala EL, et al. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry. 2002;17(7):629-634. (Pubitemid 34784718)
25. McCaffery JM, Niaura R, Todaro JF, et al. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom Med. 2003;65(3):490-497. doi:10.1097/01.PSY.041545.52924.82
26. Ergün UG, Uguz S, Bozdemir N, et al. The relationship between cholesterol levels and depression in the elderly. Int J Geriatr Psychiatry. 2004;19(3):291-296. doi:10.102/gps.1078 (Pubitemid 38401135)
27. Kim JM, Stewart R, Shin IS, et al. Vascular disease/risk and latelife depression in a Korean community population. Br J Psychiatry. 2004;185(2):102-107. doi:10.192/bjp.185.2.102 (Pubitemid 39061452)
28. Kim YK, Myint AM. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord. 2004;81(2):161-166. doi:10.1016/S0165-0327(03)016-6
29. van Reedt Dortland AK, Giltay EJ, van Veen T, et al. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2010;71(6):729-736. doi:10.408/JCP.08m04865blu
30. Sagud M, Mihaljevic-Peles A, Pivac N, et al. Lipid levels in female patients with affective disorders. Psychiatry Res. 2009;168(3):218-221. doi:10.1016/j.psychres.208.06.048
31. Lamarche B, Tchernof A, Mauriège P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279(24):1955-1961. doi:10.101/jama.279.24.195 (Pubitemid 28298273)
32. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43(9):1363-1379. doi:10.194/jlr.R204-JLR20
33. Deisenhammer EA, Kramer-Reinstadler K, Liensberger D, et al. No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Res. 2004;121(3):253-261. doi:10.1016/j.psychres.203.09. 07 (Pubitemid 37522178)
34. Kopf D, Westphal S, Luley CW, et al. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol. 2004;24(5):527-531. doi:10.1097/01.jcp.0138762.23482.63 (Pubitemid 39274207)
35. Weber-Hamann B, Kopf D, Lederbogen F, et al. Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology. 2005;81(3):200-204. doi:10.159/08703 (Pubitemid 41158960)
36. Wyeth Pharmaceuticals Inc. Effexor (venlafaxine) [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2010.